Target intelligence / Profile preview

NHP2-like protein 1 (SNU13)

Target
SNU13
Molecular classification
small nuclear ribonucleoprotein, Ribonucleoprotein complex component, RNA-binding protein
01

Overview

NHP2-like protein 1 (SNU13) is a highly conserved nuclear protein and core component of the [U4/U6.U5] tri-snRNP and box C/D small nucleolar ribonucleoprotein (snoRNP) complexes[1][2][3]. It specifically recognizes and binds a conserved RNA kink-turn motif found in the 5′ stem-loop of U4 small nuclear RNA (snRNA) and box C/D snoRNAs[1][2]. SNU13 acts as a molecular bridge, providing a platform for the association of other core sn/snoRNP proteins including NOP56, NOP58, and fibrillarin, and is critical for assembly of mature snRNPs and snoRNPs[1][2][3]. These complexes are essential for pre-mRNA splicing (especially in spliceosome function) and for site-specific modifications of ribosomal RNA during ribosome biogenesis[1][2][3]. SNU13 interacts with multiple assembly factors and chaperones (like NUFIP1, TIP48, TIP49), which help ensure correct complex formation and stability[1][4]. Structural studies have revealed that SNU13 is well-folded, with conformational flexibility important for precise RNA recognition and nucleation of ribonucleoprotein assemblies[1][2][3]. There are no direct reports of SNU13 being directly implicated as a therapeutic drug target or as a biomarker in human disease.

Other names
NHP2-like protein 1NHP2L1hSNU13FA-1SPAG12SNRNP15-515.5KHigh mobility group-like nuclear protein 2 homolog 1OTK27SNU13 homologU4/U6.U5 small nuclear ribonucleoprotein SNU13U4/U6.U5 tri-snRNP 15.5 kDa proteinsmall nuclear ribonucleoprotein 15.5kDa (U4/U6.U5)FA1NHPXSSFA1sperm specific antigen 1non-histone chromosome protein 2-like 1
02

Biological functions

Pre-mRNA splicing (splicing of messenger RNA precursors)Ribosomal RNA (rRNA) processingAssembly of small nuclear ribonucleoprotein (snRNP) and small nucleolar ribonucleoprotein (snoRNP) complexes
03

Disease associations

There is no direct involvement of SNU13 in major diseases like cancer, inflammation, or neurodegeneration documented in main sources[1][2].

Beyond the preview

Go deeper on NHP2-like protein 1 (SNU13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NHP2-like protein 1 (SNU13).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call